Madrona Venture Group
SEATTLE, WAfiles as Madrona Venture Group, LLC
$22m in 3 US stocks at the end of 31 December 2025. The top 10 are 100.0% of the money. It changed about 16.5% of the portfolio this quarter.
Value
$22m
Stocks
3
Top 10 share
100.0%
Turnover
16.5%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Nautilus BiotechnologyNAUT | 53.2% | $12m | 6,020,770 | Held |
| UiPathPATH | 45.2% | $10m | 607,673 | Held |
| Ginkgo Bioworks HoldingsDNA | 1.6% | $353,000 | 42,430 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Value is up 74.8% since 30 June 2025.
Where the money is
Health care54.8%
Technology45.2%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.